KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Other Non-Current Assets (2016 - 2025)

Teva Pharmaceutical Industries (TEVA) has disclosed Other Non-Current Assets for 16 consecutive years, with $1.8 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Assets rose 294.12% year-over-year to $1.8 billion, compared with a TTM value of $1.8 billion through Sep 2025, up 294.12%, and an annual FY2024 reading of $462.0 million, up 560.0% over the prior year.
  • Other Non-Current Assets was $1.8 billion for Q3 2025 at Teva Pharmaceutical Industries, up from $470.0 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.8 billion in Q3 2025 and bottomed at $10.0 million in Q4 2022.
  • Average Other Non-Current Assets over 5 years is $438.2 million, with a median of $459.0 million recorded in 2024.
  • The sharpest move saw Other Non-Current Assets plummeted 96.47% in 2021, then soared 675.0% in 2024.
  • Year by year, Other Non-Current Assets stood at $19.0 million in 2021, then crashed by 47.37% to $10.0 million in 2022, then skyrocketed by 600.0% to $70.0 million in 2023, then skyrocketed by 560.0% to $462.0 million in 2024, then soared by 291.56% to $1.8 billion in 2025.
  • Business Quant data shows Other Non-Current Assets for TEVA at $1.8 billion in Q3 2025, $470.0 million in Q2 2025, and $464.0 million in Q1 2025.